Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...
